Adriamycin (NSC-123127) in the treatment of acute myelocytic leukemia.
D000606:Amino Sugars / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004562:Electrocardiography; D006027:Glycosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007275:Injections, Intravenous; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D009279:Naphthacenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000606:Amino Sugars; D000903:Antibiotics, Antineoplastic; D006027:Glycosides; D009279:Naphthacenes